Delivery Order SPE2DB22D2005-SPE2DB24FJMD8
Award Date
5/6/24
Potential Completion Date
5/7/24
Potential Value
$1.4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of GEMTESA 75 MG TABLET 90S to the Defense Logistics Agency (DLA). The $11,323.19 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on July 25, 2024 with a completion date of July 26, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical,...
This federal contract award is for the delivery of GEMTESA 75 MG TABLET 90S to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The contract, valued at $1,318.56, was awarded to Amerisourcebergen Drug Corp, a for-profit subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. This contract is a firm fixed price delivery order and does not have a set-aside designation. Amerisourcebergen Drug Corp holds an Indefinite Delivery...
This federal contract award is for the delivery of GEMTESA 75 MG TABLET 90S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $8,800.41 Firm Fixed Price delivery order was awarded on December 19, 2024 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of December 20, 2024 and is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award is for the delivery of GEMTESA 75 MG TABLET 90S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $7,742.13, was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of December 11, 2024. The contract is not designated with a set-aside requirement,...
This federal contract award, SPE2DB22D3501|SPE2DB24FTF43, is for the supply of GEMTESA 75 MG TABLET 90S to the Defense Logistics Agency (DLA). The $2,274.85 fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has an ultimate completion date of October 19, 2023. AmerisourceBergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the...
This federal contract award is for the delivery of GEMTESA 75 MG TABLET 90S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, as a delivery order with a ceiling value of $47,060.33. The contract has a firm fixed price pricing type and an ultimate completion date of December 20, 2024. The contract is not associated with a set-aside designation,...
This federal contract award was made to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $11,366.88 Firm Fixed Price delivery order contract is for the provision of GEMTESA 75 MG TABLET 30S, a pharmaceutical product. The contract has a completion date of July 9, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical,...
This federal contract award is for the delivery of GEMTESA 75 MG TABLET 90S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for a ceiling value of $19,230.15. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of December 27, 2024. This contract is part of a larger Indefinite...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $13,420.56 firm-fixed-price delivery order is for the supply of GEMTESA 75 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of February 21, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of GEMTESA 75 MG TABLET 90S, a pharmaceutical product. The $13,254.30 firm fixed-price Delivery Order contract has a completion date of February 20, 2024. The award is not designated under any set-aside program. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through...